MEDNAX Inc. (MD)

43.42
NYSE : Health Services
Prev Close 43.42
Day Low/High 0.00 / 0.00
52 Wk Low/High 40.56 / 63.04
Avg Volume 797.80K
Exchange NYSE
Shares Outstanding 94.50M
Market Cap 4.16B
EPS 3.50
P/E Ratio 12.45
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Mednax, Inc. - MD

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Mednax, Inc. - MD

NEW YORK, July 11, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mednax, Inc.

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Mednax, Inc. (MD)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Mednax, Inc. (MD)

NEW YORK, July 11, 2018 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mednax, Inc.

Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Mednax, Inc. And Certain Of Its Current Senior Executives

Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Mednax, Inc. And Certain Of Its Current Senior Executives

NEW YORK, July 11, 2018 /PRNewswire/ -- Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") today announced that it filed a securities class action lawsuit on behalf of Cambridge Retirement System (" Cambridge") against Mednax, Inc.

Combatting The National Opioid Epidemic: MEDNAX Launches Second Installment Of Continuing Education Webinar Series Available To All Clinical Professionals Beginning July 10

Combatting The National Opioid Epidemic: MEDNAX Launches Second Installment Of Continuing Education Webinar Series Available To All Clinical Professionals Beginning July 10

MEDNAX, Inc. (NYSE:MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology and management services, will launch the second installment of its continuing education...

Court Prohibits Atrium Health From Soliciting Southeast Anesthesiology Physicians

Court Prohibits Atrium Health From Soliciting Southeast Anesthesiology Physicians

Statement From Southeast Anesthesiology Consultants And MEDNAX Services, Inc.

MEDNAX National Medical Group And Pacira Pharmaceuticals Launch National Enhanced Recovery After Cesarean Surgery (ERACS™) Collaborative To Minimize Opioid Use

MEDNAX National Medical Group And Pacira Pharmaceuticals Launch National Enhanced Recovery After Cesarean Surgery (ERACS™) Collaborative To Minimize Opioid Use

MEDNAX, Inc. (NYSE:MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology and management services, is pleased to announce that it has partnered with Pacira...

MedData Announces Emily Fisher As Acting President

MedData Announces Emily Fisher As Acting President

MedData, Inc., a MEDNAX (NYSE: MD) company and a leading provider of patient-facing financial services for hospitals and health systems, today announced Emily Fisher as Acting President.

MEDNAX To Present At The Jefferies 2018 Global Healthcare Conference

MEDNAX To Present At The Jefferies 2018 Global Healthcare Conference

MEDNAX, Inc. (NYSE:MD), today announced that it is scheduled to make a presentation on Friday, June 8, 2018 at 1:00 p.

MEDNAX To Present At The Bank Of America Merrill Lynch 2018 Health Care Conference

MEDNAX To Present At The Bank Of America Merrill Lynch 2018 Health Care Conference

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make a presentation on Thursday, May 17, 2018 at 8:00 a.

Statement From Southeast Anesthesiology Consultants And Mednax Services, Inc.

Statement From Southeast Anesthesiology Consultants And Mednax Services, Inc.

Southeast Anesthesiology Consultants ("Southeast"), an affiliate of MEDNAX, Inc.

Atrium Health Amends Countersuit To Mednax Due To Continued False Fear-based Ad Campaign

Struggling Florida-based Mednax using falsehoods as last-ditch effort to remain relevant in North Carolina

MEDNAX Reports First Quarter GAAP EPS Of $0.68

MEDNAX Reports First Quarter GAAP EPS Of $0.68

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings of $0.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: GOOG, GOOGL, HSII, MSA, NSA, OI, SUI Downgrades: ACXM, BWEN, DVCR, ENIC, GSUM, KMB, LII, MD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

MEDNAX Announces Acquisition Of Leading Texas Radiology Practice

MEDNAX Announces Acquisition Of Leading Texas Radiology Practice

MEDNAX, Inc. (NYSE:MD), today announced the acquisition of Women's Radiology Associates, LLP, a private radiology physician group based in Houston.

MEDNAX 2018 First Quarter Conference Call/Webcast Scheduled For Monday, May 7, 2018

MEDNAX 2018 First Quarter Conference Call/Webcast Scheduled For Monday, May 7, 2018

MEDNAX, Inc. (NYSE:MD), will host an investor conference call and webcast on Monday, May 7, 2018 at 11:00 a.

MEDNAX In Collaboration With Memorial Regional Hospital Earns National Accreditation For Adult Congenital Heart Program

MEDNAX In Collaboration With Memorial Regional Hospital Earns National Accreditation For Adult Congenital Heart Program

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology and management services, is pleased to...

MEDNAX Announces Acquisition Of Pediatric Urology Practice In South Florida

MEDNAX Announces Acquisition Of Pediatric Urology Practice In South Florida

MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Children's Urology Associates, P.

MEDNAX Announces Expansion Of Radiology Practices

MEDNAX Announces Expansion Of Radiology Practices

MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Cool Springs Interventional, LLC based in Franklin, Tenn.

MEDNAX Announces Acquisition Of Pediatric Ophthalmology Practice In Washington

MEDNAX Announces Acquisition Of Pediatric Ophthalmology Practice In Washington

MEDNAX, Inc. (NYSE:MD), today announced the acquisition of Children's Eye Care, LLC, a private pediatric ophthalmology practice based in Kirkland, Wash.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACIW, AMC, CTRP, GSIT, ITGR, JNP, KFFB, MD, MDSO, NJR, VECO Downgrades: NEM, TFX, TTEC Initiations: CNAT, OTEL Read on to get TheStreet Quant Ratings' detailed report:

Mednax Stock Sees Short Interest Drop 17.8%

Mednax Stock Sees Short Interest Drop 17.8%

The most recent short interest data has been released for the 02/15/2018 settlement date, which shows a 625,050 share decrease in total short interest for Mednax, Inc. , to 2,896,652, a decrease of 17.75% since 01/31/2018.

First Week of April 20th Options Trading For Mednax (MD)

First Week of April 20th Options Trading For Mednax (MD)

Investors in Mednax, Inc. saw new options become available this week, for the April 20th expiration.

MEDNAX Reports Fourth Quarter GAAP EPS Of $1.46

MEDNAX Reports Fourth Quarter GAAP EPS Of $1.46

MEDNAX, Inc. (NYSE:MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings of $1.

First Week of MD March 16th Options Trading

First Week of MD March 16th Options Trading

Investors in Mednax, Inc. saw new options begin trading this week, for the March 16th expiration.

MEDNAX's American Anesthesiology To Exhibit At ASA's PRACTICE MANAGEMENT 2018 Jan. 26-27

MEDNAX's American Anesthesiology To Exhibit At ASA's PRACTICE MANAGEMENT 2018 Jan. 26-27

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology and management services, is exhibiting as an...

MEDNAX 2017 Fourth Quarter Conference Call/Webcast Scheduled For Thursday, February 8, 2018

MEDNAX 2017 Fourth Quarter Conference Call/Webcast Scheduled For Thursday, February 8, 2018

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Thursday, February 8, 2018 at 10:00 a.

MEDNAX Announces Acquisition Of Neonatology Practice In California

MEDNAX Announces Acquisition Of Neonatology Practice In California

MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Tri-Valley Neonatal Medical Group, Inc.

TheStreet Quant Rating: C (Hold)